ApexBio (1733.TW) monthly revenue, September 2026

ApexBio reported revenue of NT$0.14bn for September 2026, down 4.8% from the previous month and down 23.0% from a year earlier. Year-to-date revenue was NT$1.42bn, down 5.8% year on year. It ranked 135 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.14-4.8-23.0